183 SalehiB.SharopovF.FokouP
Clin Pharmacol Ther 88:400404 McMartin KE, Makar AB, Martin G, Palese M, Tephly TR (1975) Methanol poisoning
Abbreviations CDKs: Cyclin-dependent kinases CDK5: Cyclin-dependent kinase-5 GSTP1: Glutathione S-transferase P1 EMT: Epithelial Mesenchymal Transition MTC: Medullary thyroid carcinoma ADD1: Adducin1 PPAR: Peroxisome proliferator-activated receptor PCa: Prostate cancer PDX: Patient-derived xenograft PDAC: Pancreatic ductal adenocarcinoma Ral GEFs: Ral guanine nucleotide-exchange factors EZH2: Enhancer of zeste homolog GBM: Glioblastoma PIKE: A-Phosphatidylinositol 3 kinase enhancer-A CRMP2: Collapsin response mediator protein 2 ACSS2: Acetyl-CoA synthetase 2 OGT: O-GlcNAc transferase DYRK1A: Dual-specificity tyrosine phosphorylation-regulated kinase 1 A HCC: Hepatocellular carcinoma PRMT1: Protein arginine methyltransferase 1 SCLCs: Small cell lung cancer NSCLCs: Non-small cell lung cancer LUAD: Lung adenocarcinoma hASH1: Achaete-scute homolog-1 CAP1: Adenylate cyclase associated protein 1 PD: L1-Programmed cell death ligand 1 IFN: Interferon HNSCC: Head and neck squamous cell carcinoma MM: Multiple myeloma EphA4: Eph receptor A4 ATM: Ataxia Telangiectasia Mutated DLC: 1-Deleted in Liver Cancer 1 FAK: Focal adhesion kinase PIPKI90: Phosphatidylinositol 4-phosphate 5-kinase type I 90 ERK: Extracellular signal-regulated kinase TRIM59: Tripartite motif-containing 59 RPA32: Replication protein A ESRP1: Epithelial Splicing Regulatory Protein 1 DRP1: Dynamin-related protein 1 TIGAR: TP53 induced-glycolysis regulatory phosphatase CK2: Casein kinase 2 mPTP: Mitochondrial permeability transition pore AR: Androgen receptor TNBC: Triple-negative breast cancer STAT: Signal transducer and activator of transcription References Songyang Z, Lu KP, Kwon YT, Tsai LH, Filhol O, Cochet C, et al
By delivering healing ingredients transdermally directly to the exact area that needs it most, it provides faster relief, better targeted results, and zero gastrointestinal side effects
This is particularly an issue in pediatric populations, where tools for predicting drug efficacy and developmental toxicity are not well established
